Clinical trials
Completed Phase 2 Hyperphosphatemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kyowa Kirin Co., Ltd. | 3 |
| Bayer | 2 |
| Genzyme, a Sanofi Company | 2 |
| Ineos Healthcare Limited | 2 |
| Novartis Pharmaceuticals | 2 |
| Alebund Pharmaceuticals | 1 |
| Ardelyx | 1 |
| Astellas Pharma Inc | 1 |
| KDL Inc. | 1 |
| Keryx Biopharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 22 |
| Renal Insufficiency, Chronic | 9 |
| Kidney Failure, Chronic | 5 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Kidney Diseases | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.